RAPP

23.1801.74%
JI

James Irvin Healy

Independent Director

Mr. James Irvin Healy, M.D. & Ph.D., also known as Jim, is Managing Partner & Chairperson of Sofinnova Investments, Inc. from July 2026. He joined the Sofinnova Investments, Inc. in June 2000. He focuses on United States and Europe; Life Science and Bio-Pharmaceutical. He was Lead Independent Director of Sofinnova Investments, Inc. He was Managing Partner of Sofinnova Investments, Inc. until July 2026. He is Director of BioSpace, Inc. He is CFO & Director of Net32, Inc. He was Director of Net32, Inc. He is Director of InSync Research, Inc. He is Director of Prestwick Pharmaceuticals, Inc. from February 2003. He joined the Prestwick Pharmaceuticals, Inc. in February 2003. He is Director of Sorbent Therapeutics, Inc. He is Director of InteKrin Therapeutics Inc. He is Independent Director of BioAge Labs, Inc. He was Chairman of the Board of BioAge Labs, Inc. from February 2024 to August 2024. He was Director of BioAge Labs, Inc. until February 2024. He is Independent Director of ArriVent BioPharma, Inc. from March 2023. He is Independent Director of Rapport Therapeutics, Inc. from August 2023. He is Independent Non-Employee Director of Seaport Therapeutics, Inc. from April 2024. He was Executive Officer of Bayer Corporation. He was Independent Director of CoTherix, Inc. He joined the CoTherix, Inc. in April 2001. He was Director of InterMune, Inc. He was employed at InterMune, Inc. from April 1999 to September 29, 2014. He was Director of Durata Therapeutics, Inc. He was employed at Durata Therapeutics, Inc. from December 2009 to November 15, 2013. He was Independent Director of Coherus Oncology, Inc. from February 2014 to February 04, 2022. He was employed at Coherus Oncology, Inc. from February 2014 to February 04, 2022. He was Independent Director of Edge Therapeutics, Inc. from April 09, 2015 to June 19, 2018. He was employed at Edge Therapeutics, Inc. from April 09, 2015 to June 19, 2018. He was Independent Director of Natera, Inc. from November 2014 to June 12, 2025. He was employed at Natera, Inc. from November 2014 to June 12, 2025. He was Director of Humanigen, Inc. He was employed at Humanigen, Inc. from September 2001 to June 18, 2014. He was Independent Director of Ascendis Pharma A/S from November 2014 to May 30, 2022. He was employed at Ascendis Pharma A/S from November 2014 to May 30, 2022. He was Director of Anthera Pharmaceuticals, Inc. He was employed at Anthera Pharmaceuticals, Inc. from September 2006 to March 25, 2014. He was Non Executive Director of Amarin Corporation plc. He was employed at Amarin Corporation plc from May 23, 2008 to December 20, 2016. He was Vice-Chairman of Altamira Therapeutics Ltd. until April 13, 2017. He was employed at Altamira Therapeutics Ltd. from April 01, 2013 to April 13, 2017. He was Executive Officer of ISTA Pharmaceuticals, Inc. He was Director of Novacea, Inc. He joined the Novacea, Inc. in June 2001. He was Director of Phenomix Corporation. He was Director of Cellective Therapeutics, Inc. He was Non-Executive Director of Shire-Movetis NV. He joined the Shire-Movetis NV on June 27, 2007. He was Director of NextWave Pharmaceuticals, Inc. He was Director of PregLem SA. He joined the PregLem SA in December 2007. He was Chairman of Hyperion Therapeutics, Inc. He joined the Hyperion Therapeutics, Inc. in 2006. He was Director of CEBIX Inc. He was Independent Non-Executive Director of NuCana plc from March 2014 to April 27, 2022. He was employed at NuCana plc until April 27, 2022. He was Independent Director of Karuna Therapeutics, Inc. from June 2019 to March 18, 2024. He was employed at Karuna Therapeutics, Inc. from June 2019 to March 18, 2024. He was Independent Director of ObsEva SA from August 29, 2013 to May 28, 2021. He was employed at ObsEva SA from August 29, 2013 to May 28, 2021. He was Independent Director of Iterum Therapeutics plc from November 2015 to February 12, 2020. He was employed at Iterum Therapeutics plc until February 12, 2020. He was Partner of Sanderling Ventures. He was Independent Chairman of the Board of Y-mAbs Therapeutics, Inc. from April 22, 2022 to September 16, 2025. He was Independent Director of Y-mAbs Therapeutics, Inc. from November 2017 to April 27, 2022. He was employed at Y-mAbs Therapeutics, Inc. until September 16, 2025. He was Lead Independent Director of Bolt Biotherapeutics, Inc. from November 2021 to September 2024. He was Independent Director of Bolt Biotherapeutics, Inc. from January 2021 to November 2021. He was employed at Bolt Biotherapeutics, Inc. until September 2024. He was Independent Chairman of the Board of CinCor Pharma, Inc. He was Director of CinCor Pharma, Inc. from May 2019. He was Director of Atsena Therapeutics, Inc. He has B.A. in Molecular Biology from The University of California, Berkeley, B.A. in Scandinavian Studies from The University of California, Berkeley, M.D. in Immunology from Stanford University School of Medicine, Ph.D. in Immunology from Stanford University School of Medicine.

Positions